Show simple item record

dc.contributor.authorChada, Sunil
dc.contributor.authorWhitney, Constance
dc.contributor.authorNewburger, Peter E.
dc.date2022-08-11T08:09:46.000
dc.date.accessioned2022-08-23T16:43:15Z
dc.date.available2022-08-23T16:43:15Z
dc.date.issued1989-11-15
dc.date.submitted2008-04-14
dc.identifier.citationBlood. 1989 Nov 15;74(7):2535-41.
dc.identifier.issn0006-4971 (Print)
dc.identifier.pmid2804377
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40255
dc.description.abstractWe have used a cloned cDNA for the major human selenoprotein, glutathione peroxidase (GPx), to assess the mode of regulation of human GPx gene (GPX-1) expression by selenium. When the HL-60 human myeloid cell line is grown in a selenium-deficient medium, GPx enzymatic activity decreases 30-fold compared with selenium-replete cells. Upon return to a medium containing selenium in the form of selenite, GPx activity in the cells starts to increase within 48 hours and reaches maximal (selenium-replete) levels at 7 days. Steady-state immunoreactive protein levels correlate with enzymatic activity. Cycloheximide inhibits the rise in GPx activity that accompanies selenium replenishment, indicating that protein synthesis is required for the increase. However, GPx mRNA levels and the rate of transcription of the human GPx gene change very little and thus appear to be independent of the selenium supply. Thus the human GPx gene appears to be regulated post-transcriptionally, probably cotranslationally, in response to selenium availability.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2804377&dopt=Abstract ">Link to article in PubMed</a>
dc.subjectBlotting, Western
dc.subjectCell Differentiation
dc.subjectCell Nucleus
dc.subjectCycloheximide
dc.subjectGene Expression Regulation, Leukemic
dc.subjectGlutathione Peroxidase
dc.subjectHumans
dc.subjectLeukemia, Myeloid
dc.subjectProtein Biosynthesis
dc.subjectRNA, Messenger
dc.subjectSelenium
dc.subjectTranscription, Genetic
dc.subjectTumor Cells, Cultured
dc.subjectCancer Biology
dc.subjectCell and Developmental Biology
dc.subjectHematology
dc.subjectMedical Genetics
dc.subjectPediatrics
dc.titlePost-transcriptional regulation of glutathione peroxidase gene expression by selenium in the HL-60 human myeloid cell line
dc.typeJournal Article
dc.source.journaltitleBlood
dc.source.volume74
dc.source.issue7
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1304&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/305
dc.identifier.contextkey489643
refterms.dateFOA2022-08-23T16:43:15Z
html.description.abstract<p>We have used a cloned cDNA for the major human selenoprotein, glutathione peroxidase (GPx), to assess the mode of regulation of human GPx gene (GPX-1) expression by selenium. When the HL-60 human myeloid cell line is grown in a selenium-deficient medium, GPx enzymatic activity decreases 30-fold compared with selenium-replete cells. Upon return to a medium containing selenium in the form of selenite, GPx activity in the cells starts to increase within 48 hours and reaches maximal (selenium-replete) levels at 7 days. Steady-state immunoreactive protein levels correlate with enzymatic activity. Cycloheximide inhibits the rise in GPx activity that accompanies selenium replenishment, indicating that protein synthesis is required for the increase. However, GPx mRNA levels and the rate of transcription of the human GPx gene change very little and thus appear to be independent of the selenium supply. Thus the human GPx gene appears to be regulated post-transcriptionally, probably cotranslationally, in response to selenium availability.</p>
dc.identifier.submissionpathoapubs/305
dc.contributor.departmentDepartment of Pediatrics University of Massachusetts Medical School
dc.source.pages2535-41


Files in this item

Thumbnail
Name:
2804377.pdf
Size:
1.266Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record